You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed or progressed

Showing 1 - 25 of 6,574
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)

Not yet recruiting
  • Ovarian Cancer
  • Drug Related Neoplasm/Cancer
  • (no location specified)
Jan 28, 2023

Multiple Myeloma Trial in Seoul (Carfilzomib 56 MG [Kyprolis], Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Carfilzomib 56 MG [Kyprolis]
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 19, 2022

Effect of Drug, Drug, Toxicity Trial in Beijing (Apatinib+IE, IE)

Recruiting
  • Effect of Drug
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Mar 12, 2022

Multiple Myeloma in Relapse Trial in Finland, Sweden (Carfilzomib for Inj 60 milligram (MG), Elotuzumab 400 MG, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Carfilzomib for Inj 60 milligram (MG)
  • +2 more
  • Helsinki, Finland
  • +7 more
Mar 14, 2022

Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Beijing, Beijing, China
  • +13 more
Aug 16, 2022

Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC) Trial in Poland, Spain, United States (NT-I7,

Active, not recruiting
  • Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
  • Louisville, Kentucky
  • +5 more
Dec 7, 2022

Effect of Drug, Toxicity, Drug Trial in Beijing (apatinib)

Recruiting
  • Effect of Drug
  • Toxicity, Drug
  • Beijing, Beijing, China
  • +1 more
Jul 12, 2021

Sarcoma, Kaposi, HIV Trial in United States (Etoposide)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Birmingham, Alabama
  • +19 more
Oct 27, 2021

Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)

Terminated
  • Idiopathic Multicentric Castleman's Disease
  • Lansing, Michigan
    Edward W. Sparrow Hospital
Apr 15, 2021

Melanoma Trial in United States (ipilimumab, nivolumab)

Completed
Has Results
  • Melanoma
  • Los Angeles, California
  • +6 more
Feb 2, 2021

NSCLC (NSCLC) Trial in Worldwide (Pemigatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Los Angeles, California
  • +41 more
Jun 27, 2022

Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is

Completed
  • Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate
  • Test Product (Bendamustine)
  • Long Beach, California
  • +9 more
Jun 2, 2021

Hodgkin Lymphoma Trial (pembrolizumab)

Active, not recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • (no location specified)
May 30, 2022

REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

Not yet recruiting
  • CLL, Relapsed
  • +3 more
    • Clermont-Ferrand, France
    • +7 more
    Nov 16, 2022

    Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

    Not yet recruiting
    • Relapsed Cancer
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Jun 19, 2023

    Breast Cancer, Solid Tumor, Adult Trial in United States (APG-2575, Palbociclib)

    Recruiting
    • Breast Cancer
    • Solid Tumor, Adult
    • Atlanta, Georgia
    • +3 more
    Aug 12, 2022

    DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to DLBCL Trial

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
    • +2 more
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Sep 5, 2023

    Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),

    Not yet recruiting
    • Multiple Myeloma
    • Allogeneic Stem Cells
    • +8 more
    • Freiburg, Baden-Württemberg, Germany
    • +31 more
    Jan 5, 2023

    Hodgkin's Lymphoma Trial in Houston (Azacytidine, Pembrolizumab)

    Recruiting
    • Hodgkin's Lymphoma
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 5, 2022

    Large B-cell Lymphoma Trial (Glofitamab, Polatuzumab vedotin, Obinutuzumab)

    Not yet recruiting
    • Large B-cell Lymphoma
    • (no location specified)
    Oct 3, 2023

    Classical Hodgkin Lymphoma Trial in Worldwide (Tislelizumab)

    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • Detroit, Michigan
    • +34 more
    Dec 29, 2022

    Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)

    Not yet recruiting
    • Pancreatic Cancer
    • Baltimore, Maryland
      Johns Hopkins SKCCC
    Jan 23, 2023

    Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in United Kingdom (Epcoritamab, Lenalidomide, Rituximab)

    Not yet recruiting
    • Relapsed Follicular Lymphoma
    • Refractory Follicular Lymphoma
    • Aberdeen, United Kingdom
    • +24 more
    Apr 28, 2023

    Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

    Recruiting
    • Follicular B-cell Non-Hodgkin's Lymphoma
    • +7 more
    • MB-106
    • Orange, California
    • +3 more
    Nov 1, 2022